Efficacy and safety ofPAC‐14028 cream – a novel, topical, nonsteroidal, selectiveTRPV1 antagonist in patients with mild‐to‐moderate atopic dermatitis: a phaseIIb randomized trial | Synapse
January 8, 2019Open Access
Efficacy and safety ofPAC‐14028 cream – a novel, topical, nonsteroidal, selectiveTRPV1 antagonist in patients with mild‐to‐moderate atopic dermatitis: a phaseIIb randomized trial
Key Points
Key points are not available for this paper at this time.
Abstract
PAC-14028 cream may be an effective and safe treatment modality for the treatment of patients with mild-to-moderate AD.